3561 Results

People

  1. Motzer
    Motzer
  2. Saltz
    Saltz
  3. Hudis
    Hudis
  4. O'Reilly
    O'Reilly
  5. Gonen
    Gonen
  6. Kris
    Kris
  7. D'Angelica
    D'Angelica
  8. Jarnagin
    Jarnagin
  9. Scher
    Scher
  10. Ilson
    Ilson

Groups

  1. Department of Medicine (1663)
  2. Solid Tumor Oncology Division (1185)
  3. Surgery (839)
  4. Survivorship Research (593)
  5. Hematologic Malignancies, Division of (475)
  6. Center for Hematologic Malignancies (461)
  7. GSK Faculty (449)
  8. Epidemiology and Biostatistics (352)
  9. Gastrointestinal Oncology Service (324)
  10. Population Sciences Research Program (305)
  1. "antineoplastic agent"
Formats
  1. Journal Article (3226)
  2. Review (157)
  3. Editorial (63)
  4. Conference Paper (35)
  5. Research Letter (32)
  6. Guidelines (18)
  7. Correspondence (14)
  8. Miscellaneous (8)
  9. Meeting Abstract (6)
  10. Book Section (2)
Groups
  1. Department of Medicine (1663)
  2. Solid Tumor Oncology Division (1185)
  3. Surgery (839)
  4. Survivorship Research (593)
  5. Hematologic Malignancies, Division of (475)
  6. Center for Hematologic Malignancies (461)

More Groups

People
  1. Robert Motzer (92)
  2. Leonard Saltz (72)
  3. Clifford Hudis (70)
  4. Eileen O'Reilly (65)
  5. Mithat Gonen (63)
  6. Mark Kris (58)

More People

Years
  1. 2025 (114)
  2. 2024 (308)
  3. 2023 (226)
  4. 2022 (202)
  5. 2021 (45)
  6. 2020 (99)

More Years

Publications
  1. Journal of Clinical Oncology (297)
  2. Annals of Surgical Oncology (113)
  3. Clinical Cancer Research (90)
  4. New England Journal of Medicine (74)
  5. Cancer (72)
  6. Journal of the National Comprehensive Cancer Network (72)

More Publications

Publishers
  1. Elsevier Inc. (466)
  2. American Society of Clinical Oncology (337)
  3. Springer (321)
  4. Elsevier Science, Inc. (187)
  5. Wiley Blackwell (183)
  6. Nature Publishing Group (170)

More Publishers

Results (3561)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term follow-up of the anthracyclines in early breast cancer trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])
    Journal Article

    Geyer, C. E.; Blum, J. L.; Yothers, G.; Asmar, L.; Flynn, P. J.; Robert, N. J.; Hopkins, J. O.; O'Shaughnessy, J. A.; Rastogi, P.; Puhalla, S. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab versus sunitinib in first-line treatment of advanced renal cell carcinoma: Final prespecified overall survival analysis of CLEAR, a phase III study
    Journal Article

    Motzer, R. J.; Porta, C.; Eto, M.; Powles, T.; Grünwald, V.; Hutson, T. E.; Alekseev, B.; Rha, S. Y.; Merchan, J.; Goh, J. C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
    Journal Article

    Yankelevich, M.; Thakur, A.; Modak, S.; Chu, R.; Taub, J.; Martin, A.; Schalk, D.; Schienshang, A.; Whitaker, S.; Rea, K.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Pharmacy assistance programs for oral anticancer drugs: A narrative review
    Review

    Ragavan, M. V.; Swartz, S.; Clark, M.; Chino, F.
    JCO Oncology Practice (2024)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: A phase Ib/II study
    Journal Article

    Flowers, C. R.; Matasar, M. J.; Herrera, A. F.; Hertzberg, M.; Assouline, S.; Demeter, J.; McMillan, A.; Mehta, A.; Opat, S.; Trněný, M.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series
    Journal Article

    Khan, J. S.; Piozzi, G. N.; Rouanet, P.; Saklani, A.; Ozben, V.; Neary, P.; Coyne, P.; Kim, S. H.; Garcia-Aguilar, J.
    European Journal of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study
    Journal Article

    Hoogteijling, T. J.; Abu Hilal, M.; Zimmitti, G.; Aghayan, D. L.; Wu, A. G. R.; Cipriani, F.; Gruttadauria, S.; Scatton, O.; Long, T. C. D.; Herman, P.; more...
    European Journal of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Watch & wait - Post neoadjuvant imaging for rectal cancer
    Review

    El Homsi, M.; Bercz, A.; Chahwan, S.; Fernandes, M. C.; Javed-Tayyab, S.; Golia Pernicka, J. S.; Nincevic, J.; Paroder, V.; Ruby, L.; Smith, J. J.; more...
    Clinical Imaging (2024)

    Fulltext@MSK | Save
  • A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer
    Journal Article

    Dorff, T.; Horvath, L. G.; Autio, K.; Bernard-Tessier, A.; Rettig, M. B.; Machiels, J. P.; Bilen, M. A.; Lolkema, M. P.; Adra, N.; Rottey, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save